|
 |
Dacarbazine forThis page contains recent news articles, when available, and an overview of Dacarbazine for but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Genta Announces a New Controlled Phase 3 Trial of … - Apr 18, 2007 The MAA proposes the use of Genasense plus dacarbazine for ... treatment of patients with advanced melanoma. The Company had ... efficacy results for ... Pay-Per-View - M2 Presswire - HighBeam Research Genasense(R) Marketing Authorization Application in Melanoma … - Feb 1, 2006 The application proposes the use of Genasense plus dacarbazine for treatment of patients with advanced metastatic melanoma, particularly for patients for ... $4.95 - PR Newswire - ECNext Press Release: Genta Files New Drug Application for FDA Approval of … - Dec 29, 2005 22 months for patients treated with chemotherapy ... EMEA) for use of Genasense plus dacarbazine for treatment of patients with advanced melanoma ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Completes Response to EMEA List of Outstanding … - Feb 2, 2007 Injection, in patients with advanced ... to initiate patient enrollment during ... efficacy of Genasense combined with dacarbazine for patients who have not ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genasense(R) Marketing Authorization Application in … - Feb 1, 2006 The application proposes the use of Genasense plus dacarbazine for treatment of patients with advanced metastatic melanoma, particularly for patients for ... Pay-Per-View - PR Newswire - HighBeam Research Genta Incorporated Announces Fourth Quarter and Year End 2006 … - Feb 13, 2007 Genta's Marketing Authorization Application (MAA) for the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma is currently ... $4.95 - PR Newswire - ECNext Press Release: Genta Completes Marketing Authorization Application to... - Jan 3, 2006 22 months for patients treated with chemotherapy ... EMEA) for use of Genasense plus dacarbazine for treatment of patients with advanced melanoma ... ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Updates Progress of its Phase 3 Trial of … - Jun 24, 2008 The Genasense study ... trial ever conducted in patients with advanced melanoma -- randomly assigned ... dacarbazine for treatment of patients with advanced ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Announces Expectation of a Negative Opinion from... - Mar 23, 2007 The Genasense study ... trial ever conducted in patients with advanced melanoma -- randomly assigned ... dacarbazine for treatment of patients with advanced ... Pay-Per-View - PR Newswire - HighBeam Research Genta Incorporated Announces Third Quarter 2006 Financial Results and... - Nov 7, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - PR Newswire - ECNext Press Release: Genta Cites Publication of Study Showing Improved … - Feb 14, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Pay-Per-View - M2 Presswire - HighBeam Research Genta Receives Designation as a Small/Medium Enterprise by the … - Mar 16, 2006 The MAA proposes the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. Summary data that support this application can be ... $4.95 - PR Newswire - ECNext Press Release: Genta Appeals FDA Decision on Genasense(R) in CLL. - … - Apr 4, 2007 Injection, in patients with advanced ... to initiate patient enrollment during ... efficacy of Genasense combined with dacarbazine for patients who have not ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Final Report of Genasense Phase 3 Trial in Melanoma … - Sep 15, 2006 22 months for patients treated with chemotherapy ... EMEA) for use of Genasense plus dacarbazine for treatment of patients with advanced melanoma ... ... Pay-Per-View - PR Newswire - HighBeam Research New FDA Orphan Drugs: Amplimexon, AP23573, TQ-1017 - Sep 6, 2005 It is currently in phase 1/2 clinical studies in combination with gemcitabine for the treatment of pancreatic cancer, and with dacarbazine for the treatment ... Medscape Press Release: Genasense(R) Chemotherapy Program Yields High … - May 30, 2008 EMEA) for use of Genasense plus dacarbazine for ... business conducted by Genta Incorporated. By their nature ... regulatory approval for Genasense(R) from ... Pay-Per-View - PR Newswire - HighBeam Research Highlights of rising and falling US stocks. - Feb 2, 2006 The application proposes the use of Genasense plus dacarbazine for treatment of patients with advanced metastatic melanoma, the Berkeley Heights, ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com … I/II Trial of Amplimexon plus Dacarbazine for Treatment of... - Jul 13, 2005 TUCSON, Ariz. -- AmpliMed today announced that the Company has begun to enroll patients in a new clinical trial that will evaluate its lead candidate, ... $4.95 - Business Wire - ECNext Phase III: temozolomide fails to improve melanoma survival.(News) | … - Nov 1, 2008 Phase III: temozolomide fails to improve melanoma survival.(News) ... find Skin & Allergy News articles. STOCKHOLM -- Extended-schedule, escalated-dose ... Pay-Per-View - Skin & Allergy News - HighBeam Research Genta files Letter of Intent for Genasense MAA.(Brief Article) - Jul 11, 2005 Application for Genasense (oblimersen sodium) Injection for use with dacarbazine for the treatment of chemotherapy-naive metastatic melanoma. ... $4.95 - Pharma Marketletter - ECNext Genta and IDIS Announce Global Ex-US Agreement for Named Patient/ … - Mar 7, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Free with registration - PR Newswire - AccessMyLibrary.com Briefing Documents Posted for FDA Committee Review of Genasense(R) … - Sep 5, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Multiple Presentations Report Active Combinations of … - May 17, 2005 EMEA) for use of Genasense plus dacarbazine for ... business conducted by Genta Incorporated. By their nature ... regulatory approval for Genasense(R) from ... Pay-Per-View - PR Newswire - HighBeam Research Genta Announces Expectation of a Negative Opinion from the CHMP on … - Mar 23, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Pilot Clinical Study of Genasense(R) Plus Rituxan(R)... - Dec 12, 2005 EMEA) for use of Genasense plus dacarbazine for ... business conducted by Genta Incorporated. By their nature ... regulatory approval for Genasense(R) from ... Pay-Per-View - PR Newswire - HighBeam Research CHMP Adopts Negative Opinion on Genasense(R) Application in … - Apr 27, 2007 The MAA proposes the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. The Company had previously announced its ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Initiates Pilot Clinical Trial of Genasense(R) Plus Abraxane(R)... - Nov 29, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... RedOrbit Press Release: Genasense(R) Enhances Preclinical Activity of Tarceva ... - Nov 15, 2005 EMEA) for use of Genasense plus dacarbazine for ... business conducted by Genta Incorporated. By their nature ... regulatory approval for Genasense(R) from ... Pay-Per-View - PR Newswire - HighBeam Research Genta Incorporated Receives Notice from the European Medicines … - Apr 30, 2007 The MAA proposes the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. The Company had previously announced its ... Free with registration - M2 Presswire - AccessMyLibrary.com FDA Extends Review Period For Genasense(R) New Drug Application In … - Oct 31, 2006 Genta has completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... Medical News Today - Medical News Today (press release) Press Release: Genta Announces 3rd Quarter 2005 Financial Results. - ... - Nov 7, 2005 Injection, in patients with advanced ... to initiate patient enrollment during ... efficacy of Genasense combined with dacarbazine for patients who have not ... Pay-Per-View - PR Newswire - HighBeam Research EMEA Indicates that Genasense(R) Approval in Melanoma Will Require … - Jul 19, 2007 The MAA proposed the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. In its review, the EMEA rapporteurs indicated that ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Revises Notice of Special Protocol Assessment for Confirmatory ... - Aug 18, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Chemo Plus Involved-Field Radiation Best for Early Hodgkin"s Disease - Nov 8, 2007 NEW YORK NOV 08, 2007 (Reuters Health) - Patients with early-stage Hodgkin"s disease have better outcomes when chemotherapy is followed by involved-field ... Cancerpage.com Genasense(R) New Drug Application Accepted for Review by FDA. - Mar 1, 2006 Genta has also filed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... Free with registration - PR Newswire - AccessMyLibrary.com AMPLIMED PICKS UP THIRD CANCER DRUG FROM UNIVERSITY OF … - Aug 10, 2005 The drug also is in two ongoing Phase I/II trials to evaluate it in combination with dacarbazine for malignant melanoma and in combination with gemcitabine ... Pay-Per-View - BIOWORLD Today - Factiva, from Dow Jones Phase 2 Results of Genasense(R) Plus Chemotherapy in Advanced … - Feb 23, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Genetic Engineering News - Genetic Engineering News (press release) Genta Receives Special Protocol Assessment from FDA for Confirmatory ... - Jul 26, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Announces a New Controlled Phase 3 Trial of Genasense(R) in … - Apr 18, 2007 The trial is designed to expand evidence for the safety and efficacy of Genasense combined with dacarbazine for patients who have not previously been ... Free with registration - M2 Presswire - AccessMyLibrary.com Press Release: Genta Receives Non-Approvable Notice for Application... - Dec 14, 2006 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... FierceBiotech Genta Receives Special Protocol Assessment From FDA For Randomized … - Oct 7, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) Randomized Trial Shows Ganite(R) Effective When Compared with a … - Mar 2, 2006 Genta has also submitted a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Incorporated Announces Fourth Quarter and Year End 2005 … - Mar 10, 2006 Genta completed submission of its Marketing Authorization Application (MAA) for Genasense plus dacarbazine for treatment of patients with advanced melanoma. ... Free with registration - PR Newswire - AccessMyLibrary.com EMEA accepts Genta's MA for Genasense.(European Agency for the … - Feb 6, 2006 The application proposes the use of Genasense plus dacarbazine for the treatment of patients with advanced metastatic melanoma, particularly for those with ... Free with registration - Pharma Marketletter - AccessMyLibrary.com International Approvals: Tasmar, Amplimexon, IV Remodulin - Jan 17, 2006 ...with dacarbazine for the treatment of metastatic melanoma in chemotherapy-naive patients; with docetaxel injection for the treatment of lung, breast, ... Medscape Genta Restructures Operations to Focus on Future Initiatives. - Dec 20, 2006 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Free with registration - PR Newswire - AccessMyLibrary.com Briefing of Charles Genta Incorporated. - Jun 21, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - M2 Presswire - AccessMyLibrary.com Phase 2 Results Of Genasense(R) Plus Chemotherapy In Advanced … - Feb 24, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Medical News Today - Medical News Today (press release) Relapsed Or Refractory Chronic Lymphocytic Leukemia - Genasense(R) … - Mar 3, 2006 Genta has also filed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... Medical News Today - Medical News Today (press release) Antisense Drug Targeting c-myb Oncogene Starts Phase 1 Trial in … - Oct 13, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Genetic Engineering News - Genetic Engineering News (press release) Clinical Benefit Analysis of Genasense plus Chemotherapy Reported … - Feb 15, 2006 Genta has also filed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Incorporated to Present at the Lazard Capital Markets Third... - Nov 20, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Clinical Programs Featured in Presentations at Annual Meeting... - Dec 4, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Announces FDA's Oncology Drug Advisory Committee Will Review … - Jul 28, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) Eradication of Minimal Residual Disease Reported in Patients With … - Jun 3, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... RedOrbit Genasense(R) Mechanisms of Action With Chemotherapy and Radiation … - Apr 5, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... RedOrbit Subcutaneous Genasense(R) Trial Initiated in Patients With Solid... - Jan 24, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... RedOrbit Genta Seeks Therapeutic Product Approval - Apr 1, 2006 ...(MAA) to the European Medicines Agency for the approval of Genasense in combination with dacarbazine for the treatment of advanced malignant melanoma. ... Genetic Engineering News - Genetic Engineering News (press release) Genta Announces Closing of Common Stock Offering - Sep 25, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Genetic Engineering News - Genetic Engineering News (press release) Genta Provides Update On Analysis Of Phase 3 Trial Of Genasense(R) In... - Dec 9, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) Genta Announces Common Stock Offering of Approximately $16 Million. - Sep 19, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Incorporated to Host Conference Call to Discuss Second Quarter ... - Aug 1, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genasense Not Approvable' In CLL; Europe's Ruling Next - Dec 18, 2006 ...the European Medicines Agency and expects word on whether marketing clearance will be granted to Genasense (oblimersen) plus dacarbazine for melanoma. ... BioWorld Online - BioWorld Online Genta Initiates Pilot Clinical Trial Of Genasense(R) Plus Abraxane(R)... - Nov 30, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) Genta Announces Resignation of Jerome Groopman, MD from the Board … - Jul 21, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Genetic Engineering News - Genetic Engineering News (press release) Genta Announces Common Stock Offering of Approximately $11 Million. - Mar 14, 2007 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Free with registration - PR Newswire - AccessMyLibrary.com Genta Incorporated to Present in Roundtable and Corporate Sessions at... - Feb 7, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Free with registration - PR Newswire - AccessMyLibrary.com Genasense(R) Shown Active Using Intermittent Dosing In Melanoma … - Nov 10, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) FDA Extends Review Period for Genasense(R) New Drug Application in … - Oct 30, 2006 Genta has completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... $4.95 - PR Newswire - ECNext New Analyses From Phase 3 Trial In CLL Identify Relapsed Patients Who... - Nov 9, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Medical News Today - Medical News Today (press release) Scientific Presentations to Highlight Genta's Lead Anticancer Drug … - Oct 27, 2006 Genta has completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... Genetic Engineering News - Genetic Engineering News (press release) … Trial Results for Amplimexon plus Dacarbazine for Treatment of... - Sep 14, 2006 NOORDWIJK, The Netherlands & TUCSON, Ariz. -- AmpliMed today announced interim results from the ongoing Phase I/II clinical trial of its lead drug candidate ... $4.95 - Business Wire - ECNext Genta Appoints Seasoned Pharma Executive, Lloyd Sanders, as Vice- … - Jan 17, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - PR Newswire - ECNext Genta Incorporated announces phase 3 trial of Genasense in patients … - Apr 19, 2007 The trial is designed to expand evidence for the safety and efficacy of Genasense combined with dacarbazine for patients who have not previously been ... News-Medical.net Press Release: Genta Revises Notice of Special Protocol Assessment... - Aug 18, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Briefing Documents Posted for FDA Committee Review of ... - Sep 5, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Releases Coverage for Pharmion Corporation. - M2 … - Sep 25, 2006 ...expects to initiate patient enrollment during the ... with dacarbazine for patients who have not previously ... overall and progression-free survival. ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Proxy Resolutions for Genta Incorporated Approved at … - Jun 16, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Receives Special Protocol Assessment from FDA … - Jul 26, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Receives Special Protocol Assessment from FDA … - Oct 6, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Bellwether Report.com Issues an Awareness for Genta … - Sep 18, 2006 Genasense (oblimersen sodium) Injection, in ... evidence for the safety and efficacy of Genasense combined with dacarbazine for patients ... ... Pay-Per-View - M2 Presswire - HighBeam Research Genta Incorporated to Present at the Rodman & Renshaw 8th Annual … - Nov 2, 2006 Genta has completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment of ... $4.95 - PR Newswire - ECNext Genta Incorporated to Present at Rodman & Renshaw 3rd Annual Global … - May 10, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - PR Newswire - ECNext Press Release: Subcutaneous Genasense(R) Trial Initiated in Patients ... - Jan 24, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Genasense(R) Featured in Multiple Abstracts at the Annual Meeting of... - May 30, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - PR Newswire - ECNext Press Release: Genasense(R) Triple Combination Therapy in Advanced … - Nov 8, 2007 EMEA) for use of Genasense plus dacarbazine for ... business conducted by Genta Incorporated. By their nature ... regulatory approval for Genasense(R) from ... Pay-Per-View - PR Newswire - HighBeam Research Genta provides update on analysis of phase III trial of Genasense in... - Dec 8, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Press Release: Genta Incorporated Announces Fourth Quarter and Year … - Feb 13, 2007 Genta's Marketing Authorization Application (MAA) for the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma is currently ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Restructures Operations to Focus on Future … - Dec 20, 2006 Genta has completed a pending Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Announces Closing of Common Stock Offering. - … - Mar 13, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Antisense Drug Targeting c-myb Oncogene Starts Phase … - Oct 13, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Incorporated To Webcast Conference Call on … - Mar 8, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Genta Announces New Phase 3 Trial of Genasense(R) in … - Apr 18, 2007 The trial is designed to expand evidence for the safety and efficacy of Genasense combined with dacarbazine for patients who have not previously been ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: CHMP Adopts Negative Opinion on Genasense(R) … - Apr 27, 2007 The MAA proposes the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. The Company had previously announced its ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Reports on Major Movement in Biopharmaceutical Sector.... - Feb 2, 2006 The application proposes the use of Genasense plus dacarbazine for treatment of patients with advanced metastatic melanoma, particularly for patients for ... Pay-Per-View - M2 Presswire - HighBeam Research The Bellwether Report continues to watch Genta Inc. - Feb 3, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - M2 Presswire - ECNext Press Release: Genta Announces Webcast of 2006 Annual Shareholders' … - Jun 8, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research Genta Announces Closing of Common Stock Offering. - Mar 13, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... $4.95 - PR Newswire - ECNext Press Release: Genta Incorporated Hosts Conference Call to Discuss … - May 4, 2006 Genta has also completed a Marketing Authorization Application to the European Medicines Agency (EMEA) for use of Genasense plus dacarbazine for treatment ... Pay-Per-View - PR Newswire - HighBeam Research |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |